Literature DB >> 9369244

Cardiac myocytes and fibroblasts contain functional estrogen receptors.

C Grohé1, S Kahlert, K Löbbert, M Stimpel, R H Karas, H Vetter, L Neyses.   

Abstract

Gender-based differences found in cardiovascular diseases raise the possibility that estrogen may have direct effects on cardiac tissue. Therefore we investigated whether cardiac myocytes and fibroblasts express functional estrogen receptors. Immunofluorescence demonstrated estrogen receptor protein expression in both female and male rat cardiac myocytes and fibroblasts. Nuclear translocation of the estrogen receptor protein was observed after stimulation of cardiomyocytes with 17beta-estradiol (E2). Cells transfected with an estrogen-responsive reporter plasmid showed that treatment with E2 induced a significant increase in reporter activity. Furthermore, E2 induced a significant increase in expression of the estrogen receptors alpha and beta, progesterone receptor and connexin 43 in cardiac myocytes. Cardiac myocytes and fibroblasts contain functional estrogen receptors and estrogen regulates expression of specific cardiac genes. These data suggest that gender-based differences in cardiac diseases may in part be due to direct effects of estrogen on the heart.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9369244     DOI: 10.1016/s0014-5793(97)01179-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  78 in total

1.  Effects of gender difference on cardiac myocyte dysfunction in streptozotocin-induced diabetic rats.

Authors:  Yanfeng Ding; Ruijiao Zou; Robert L Judd; Juming Zhong
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 2.  Sex is a potent modifier of the cardiovascular system.

Authors:  Leslie A Leinwand
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

3.  Inhibition of apoptosis by progesterone in cardiomyocytes.

Authors:  Stephen Morrissy; Beibei Xu; David Aguilar; Jack Zhang; Qin M Chen
Journal:  Aging Cell       Date:  2010-10       Impact factor: 9.304

4.  Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β.

Authors:  Han Liu; Ali Pedram; Jin Kyung Kim
Journal:  Cardiovasc Res       Date:  2010-08-19       Impact factor: 10.787

Review 5.  The Role of Estrogen and Estrogen Receptors on Cardiomyocytes: An Overview.

Authors:  Tao Luo; Jin Kyung Kim
Journal:  Can J Cardiol       Date:  2015-11-02       Impact factor: 5.223

6.  Comparison of the effects of new and conventional hormone replacement therapies on left ventricular diastolic function in healthy postmenopausal women: a Doppler and ultrasonic backscatter study.

Authors:  Hamza Duygu; Levent Akman; Filiz Ozerkan; Fuat Akercan; Mehdi Zoghi; Sanem Nalbantgil; Umit Erturk; Azem Akilli; Remzi Onder; Mustafa Akin
Journal:  Int J Cardiovasc Imaging       Date:  2009-02-05       Impact factor: 2.357

7.  Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice.

Authors:  S Jeson Sangaralingham; M Yat Tse; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2007-08-23       Impact factor: 3.396

8.  Expression of glucocorticoid-induced leucine zipper (GILZ) in cardiomyocytes.

Authors:  David C Aguilar; Josh Strom; Beibei Xu; Kyle Kappeler; Qin M Chen
Journal:  Cardiovasc Toxicol       Date:  2013-06       Impact factor: 3.231

9.  Menstrual cycle and ST height.

Authors:  Susanne Endres; Kenneth A Mayuga; Alessandro de Cristofaro; Taresh Taneja; Jeffrey J Goldberger; Alan H Kadish
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

10.  17beta-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts.

Authors:  Shokoufeh Mahmoodzadeh; Elke Dworatzek; Stephan Fritschka; Thi Hang Pham; Vera Regitz-Zagrosek
Journal:  Cardiovasc Res       Date:  2009-10-27       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.